Similar articles for PMID: 35168933

Year	Number of Results
2007	1
2010	1
2013	1
2014	4
2015	6
2016	5
2017	22
2018	20
2019	15
2020	17
2021	18
2022	9
2023	5
2024	0

1

Mandatory nonmedical switching from originator to biosimilar infliximab in patients with inflammatory arthritis and psoriasis in British Columbia: a cohort study.

Fisher A, Kim JD, Dormuth CR. Fisher A, et al. CMAJ Open. 2022 Feb 15;10(1):E109-E118. doi: 10.9778/cmajo.20200319. Print 2022 Jan-Mar. CMAJ Open. 2022. PMID: 35168933 Free PMC article.

2

Rapid monitoring of health services utilization following a shift in coverage from brand name to biosimilar drugs in British Columbia-An interim report.

Fisher A, Kim JD, Dormuth CR. Fisher A, et al. Pharmacoepidemiol Drug Saf. 2020 Jul;29(7):803-810. doi: 10.1002/pds.5008. Epub 2020 May 28. Pharmacoepidemiol Drug Saf. 2020. PMID: 32463156

3

A rapid monitoring plan following a shift in coverage from brand name to biosimilar drugs for rheumatoid arthritis in British Columbia.

Dormuth CR, Fisher A, Carney G. Dormuth CR, et al. Pharmacoepidemiol Drug Saf. 2020 Jul;29(7):796-802. doi: 10.1002/pds.4957. Epub 2020 Jan 8. Pharmacoepidemiol Drug Saf. 2020. PMID: 31914214

4

The nocebo effect challenges the non-medical infliximab switch in practice.

Boone NW, Liu L, Romberg-Camps MJ, Duijsens L, Houwen C, van der Kuy PHM, Janknegt R, Peeters R, Landewé RBM, Winkens B, van Bodegraven AA. Boone NW, et al. Eur J Clin Pharmacol. 2018 May;74(5):655-661. doi: 10.1007/s00228-018-2418-4. Epub 2018 Jan 24. Eur J Clin Pharmacol. 2018. PMID: 29368188 Free PMC article.

5

Rapid monitoring of health services use following a policy to switch patients from originator to biosimilar etanercept-a cohort study in British Columbia.

Fisher A, Kim JD, Carney G, Dormuth C. Fisher A, et al. BMC Rheumatol. 2022 Jan 27;6(1):5. doi: 10.1186/s41927-021-00235-x. BMC Rheumatol. 2022. PMID: 35081991 Free PMC article.

6

Monitoring a Mandatory Nonmedical Switching Policy from Originator to Biosimilar Infliximab in Patients with Inflammatory Bowel Diseases: A Population-Based Cohort Study.

Fisher A, Kim JD, Dormuth CR. Fisher A, et al. Gastroenterol Res Pract. 2023 Mar 1;2023:2794220. doi: 10.1155/2023/2794220. eCollection 2023. Gastroenterol Res Pract. 2023. PMID: 36911254 Free PMC article.

7

The Impact of Mandatory Nonmedical Switching From Originator to Biosimilar Insulin Glargine.

Fisher A, Kim JD, Dormuth C. Fisher A, et al. Clin Ther. 2022 Jul;44(7):957-970.e12. doi: 10.1016/j.clinthera.2022.05.003. Epub 2022 Jun 10. Clin Ther. 2022. PMID: 35691731

8

Efficacy, immunogenicity and cost analysis of a systematic switch from originator infliximab to biosimilar CT-P13 of all patients with inflammatory arthritis from a single center.

Valido A, Silva-Dinis J, Saavedra MJ, Iria I, Gonçalves J, Lopes JP, Fonseca JE. Valido A, et al. Acta Reumatol Port. 2019 Oct-Dec;44(4):303-311. Acta Reumatol Port. 2019. PMID: 31754088 Free article. English.

9

Infliximab biosimilar-to-biosimilar switching in patients with inflammatory rheumatic disease: clinical outcomes in real-world patients from the DANBIO registry.

Nabi H, Hendricks O, Jensen DV, Loft AG, Pedersen JK, Just SA, Danebod K, Munk HL, Kristensen S, Manilo N, Colic A, Linauskas A, Thygesen PH, Christensen LB, Kalisz MH, Lomborg N, Chrysidis S, Raun JL, Andersen M, Mehnert F, Krogh NS, Hetland ML, Glintborg B. Nabi H, et al. RMD Open. 2022 Nov;8(2):e002560. doi: 10.1136/rmdopen-2022-002560. RMD Open. 2022. PMID: 36418087 Free PMC article.

10

Characteristics and outcomes of rheumatoid arthritis patients who started biosimilar infliximab.

Sung YK, Cho SK, Kim D, Won S, Choi CB, Bang SY, Hong SJ, Kim HA, Koh EM, Lee HS, Suh CH, Yoo DH, Bae SC. Sung YK, et al. Rheumatol Int. 2017 Jun;37(6):1007-1014. doi: 10.1007/s00296-017-3663-z. Epub 2017 Feb 18. Rheumatol Int. 2017. PMID: 28214924

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

106 results

Results by year